Rx only · Tablet · Oral

Dibasic Sodium Phosphate, Monobasic Potassium Phosphate And Monobasic Sodium Phosphate

Brands: Phospha 250 Neutral · Potassium Phosphate, Monobasic + Sodium Phosphate, Dibasic, Anhydrous + Sodium Phosphate, Monobasic, Monohydrate

1 ACTIVE SUPPLIER — US

openFDA · updated weekly

US2 NDCs
1 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATC—

RxCUI (US)—

US makers1 labelers

Packages2

DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.264

Latest avg · Jul 22, 2026

+10%

Since Dec 17, 2025

Active US suppliers

100%

Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

10K

Rx · 2026 Q1

1.0M

Units dispensed

-28%

Rx vs. year ago

Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Rising Pharma Holdings, Inc.	unknown	2	SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.